• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Panacea Biotec Limited — Board Meeting, 30-05-2026: Outcome of Board Meeting

    30-05-2026 | 10:39 pm

    Panacea Biotec's Board approved Q4 & FY26 consolidated financial results, reporting a ₹7.16 Cr annual loss. No dividend declared due to losses. Mr. Rajinder Singh Manku was appointed as an independent director. Dengue vaccine Phase-III trials completed, targeting 2027 market entry.

    No comments yet. Be the first to comment!

    All announcements from Panacea Biotec Limited